Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0483 Transporter Info | ||||
Gene Name | SLC9A3 | ||||
Transporter Name | Sodium/hydrogen exchanger 3 | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Chemical Compound |
|||||
DT Modulation1 |
Valproic Acid results in increased methylation of SLC9A3 gene | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
3-(2-(3-guanidino-2-methyl-3-oxo-propenyl)-5-methylphenyl)-N-isopropylidene-2-methyl-acrylamide dihydrochloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
3-(2-(3-guanidino-2-methyl-3-oxo-propenyl)-5-methylphenyl)-N-isopropylidene-2-methyl-acrylamide dihydrochloride results in decreased activity of SLC9A3 protein | [9] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SLC9A3 mRNA | [10] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Agent Orange |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Defoliants, Chemical results in increased abundance of Agent Orange which results in increased abundance of Tetrachlorodibenzodioxin which results in decreased methylation of SLC9A3 gene | [11] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Benzo(a)pyrene |
4 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Benzo(a)pyrene affects the methylation of SLC9A3 intron | [13] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Benzo(a)pyrene affects the methylation of SLC9A3 promoter | [14] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Benzo(a)pyrene results in increased methylation of SLC9A3 5' UTR | [14] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation4 |
Benzo(a)pyrene results in increased methylation of SLC9A3 exon | [14] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
benzo(e)pyrene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
benzo(e)pyrene results in increased methylation of SLC9A3 intron | [13] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol A |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol A co-treated with Fulvestrant results in increased methylation of SLC9A3 gene | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
bisphenol A results in increased methylation of SLC9A3 gene | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol S |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol S co-treated with Fulvestrant results in decreased methylation of SLC9A3 gene | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
bisphenol S results in decreased methylation of SLC9A3 gene | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Cisplatin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cisplatin co-treated with jinfukang results in increased expression of SLC9A3 mRNA | [7] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Fulvestrant |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol A co-treated with Fulvestrant results in increased methylation of SLC9A3 gene | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
bisphenol S co-treated with Fulvestrant results in decreased methylation of SLC9A3 gene | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Methapyrilene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Methapyrilene results in increased methylation of SLC9A3 intron | [13] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
NVP-BKM120 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sotorasib co-treated with trametinib co-treated with NVP-BKM120 results in decreased expression of SLC9A3 mRNA | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Sodium Chloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Resveratrol results in increased expression of SLC9A3 protein which results in increased uptake of Sodium Chloride | [6] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
sotorasib |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sotorasib co-treated with trametinib co-treated with NVP-BKM120 results in decreased expression of SLC9A3 mRNA | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Tetrachlorodibenzodioxin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Defoliants, Chemical results in increased abundance of Agent Orange which results in increased abundance of Tetrachlorodibenzodioxin which results in decreased methylation of SLC9A3 gene | [11] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
trametinib |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sotorasib co-treated with trametinib co-treated with NVP-BKM120 results in decreased expression of SLC9A3 mRNA | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Carcinogen |
|||||
Arsenic |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Arsenic affects the methylation of SLC9A3 gene | [12] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Natural Product |
|||||
DT Modulation1 |
Plant Extracts co-treated with Resveratrol results in decreased expression of SLC9A3 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Resveratrol results in increased expression of SLC9A3 protein which results in increased uptake of Sodium Chloride | [6] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Approved Drug |
|||||
Dexamethasone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Dexamethasone increases the expression of SLC9A3 | [1] | |||
Valproic Acid |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Valproic Acid increases the expression of SLC9A3 | [2] | |||
Decitabine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Decitabine increases the expression of SLC9A3 | [3] | |||
Folic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Folic Acid inhibits the expression of SLC9A3 | [4] | |||
Fluorouracil |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Fluorouracil inhibits the expression of SLC9A3 | [5] | |||
Drug in Phase 3 Trial |
|||||
Resveratrol |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Resveratrol increases the expression of SLC9A3 | [6] | |||
Traditional Medicine |
|||||
Jinfukang |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Jinfukang increases the expression of SLC9A3 | [7] | |||
Acute Toxic Substance |
|||||
Acrylamide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acrylamide inhibits the expression of SLC9A3 | [8] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.